Anti-leukaemic activity of a novel bioactive peptide, QUB-2392, against human leukaemia cell lines by proteomics and gene profiling

Description

• Significance: Delivered a seminar at Middlesex University, London, highlighting my primary findings of QUB-2392 using proteomics and gene profiling. This research has laid the groundwork for the current proposal by identifying the molecular pathways targeted by QUB-2392 in leukaemia cell lines.
• Contribution: As the presenter, I communicated key discoveries on how QUB-2392 induces apoptosis, highlighting its potential as a therapeutic agent. This seminar fostered academic discussions and collaborations.
• Impact: Increased awareness of innovative peptide-based therapies within the academic and research community, encouraging interdisciplinary approaches to cancer treatment.

Period	11 Jan 2024
Held at	Middlesex University, United Kingdom
Degree of Recognition	National